Back to results
US 2017/0096471 A1Published application
Soluble tumor necrosis factor receptor treatment of medical disorders
AssigneeImmunex Corporation
InventorBarbara K. Finck
Life of this patent
Estimating the term…
Abstract
The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNFα by administering a TNFα antagonist, such as recombinant TNFR:Fc.
Claims18
A method for treating a patient having psoriasis comprising administering to the patient a therapeutically effective dose of TNFR:Fc.
Dependencies are inferred from the claim text.